Novelion Therapeutics Inc. (NVLN)


Novelion Therapeutics Inc. (NVLN)

$0.70 USD

0.06 (-7.89%)

Updated Aug 22 8:00pm

Add NVLN to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 329 in Biotech

See all “A” rated Strong Buy stocks

NVLN Daily Price Range
NVLN 52-Week Price Range

NVLN Stock Chart More Charts


NVLN Price/Volume Stats

Current price $0.70
Prev. close $0.76
Day low $0.67
Day high $0.72
50-day MA $0.74
200-day MA $1.03
52-week high $4.09
52-week low $0.60
Volume 73,700
Avg. volume 195,515
Dividend yield N/A
Market Cap 13.33M

Novelion Therapeutics Inc. (NVLN) Company Bio


Novelion Therapeutics is a biopharmaceutical company dedicated to developing new standards of care for individuals living with rare diseases. The company seeks to advance its portfolio of rare disease therapies by investing in science and clinical development. Novelion has a diversified commercial portfolio through its indirect subsidiary, Aegerion Pharmaceuticals, Inc., which includes MYALEPT® and JUXTAPID®, and is also developing zuretinol acetate for the treatment of inherited retinal disease caused by underlying mutations in RPE65 or LRAT genes.





NVLN News Stream


Event/Time News Detail
Loading, please wait...

NVLN Social Stream


Loading social stream, please wait...

View Full NVLN Social Stream

NVLN Returns

1-mo 0.01%
3-mo -20.45%
6-mo -45.31%
1-year -78.46%
3-year -90.28%
5-year -97.44%
YTD -16.67%
2018 -73.08%
2017 -62.95%
2016 -36.69%
2015 -33.67%
2014 -28.01%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.4094 seconds.